Marked reduction of tardive dyskinesia with olanzapine

被引:52
|
作者
Littrell, KH
Johnson, CG
Littrell, S
Peabody, CD
机构
关键词
D O I
10.1001/archpsyc.55.3.279
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:279 / 280
页数:2
相关论文
共 50 条
  • [21] Olanzapine in the treatment of tardive dyskinesia: A report of 2 cases
    Agarwal, V
    Kumar, P
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (04) : 298 - 299
  • [22] Olanzapine in the treatment of tardive dyskinesia: A report of two cases
    Soutullo, CA
    Keck, PE
    McElroy, SL
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) : 100 - 101
  • [23] Rapid onset of tardive dyskinesia in Huntington disease with olanzapine
    Benazzi, F
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (04) : 438 - 439
  • [24] Tardive dyskinesia from risperidone and olanzapine in an alcoholic man
    Snoddgrass, PL
    Labbate, LA
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1999, 44 (09): : 921 - 921
  • [25] Reduction of tardive dyskinesia with quetiapine
    Farah, A
    SCHIZOPHRENIA RESEARCH, 2001, 47 (2-3) : 309 - 310
  • [26] TARDIVE-DYSKINESIA - MARKED PREDOMINANCE OF NONGENETIC SCHIZOPHRENIA
    BARTELS, M
    MANN, K
    FRIEDRICH, W
    BIOLOGICAL PSYCHIATRY, 1985, 20 (01) : 101 - 103
  • [27] Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
    Praharaj, Samir Kumar
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (01) : 93 - 93
  • [28] Effect of chronic olanzapine treatment on the course of presumptive tardive dyskinesia
    Kinon, BJ
    Basson, BR
    Stauffer, VL
    Tollefson, GD
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 363 - 363
  • [29] What is the differential risk of tardive dyskinesia with the novel antipsychotic olanzapine?
    Tamura, RN
    Beasley, CM
    Dellva, MA
    Glazer, WM
    Morgenstern, H
    Tollefson, GD
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 176 - 176
  • [30] Olanzapine reversal of jaw movements in rat model of tardive dyskinesia
    Rosengarten, H
    Lin, Y
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S264 - S264